## Abstract Gastrointestinal stromal tumors (GISTs) are a specific and rare subset of human gastrointestinal tract tumors. Most GISTs show gain‐of‐function mutations of __KIT__, mainly in exon 11, that always maintain the reading frame. We report on data from a 43‐year‐old Japanese man with recurre
Detection of a new mutation in KIT exon 9 in a gastrointestinal stromal tumor
✍ Scribed by Isabelle Hostein; Michel Longy; Bernadette Gastaldello; Gaëlle Geneste; Jean-Michel Coindre
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- French
- Weight
- 198 KB
- Volume
- 118
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Gastrointestinal stromal tumors are mesenchymal tumors arising in the stomach and small bowel and more rarely in the rectum, esophagus, peritoneum and retroperitoneum. These tumors are characterized by KIT or PDGFRA mutations. KIT mutations are all in frame and lead to constitutive tyrosine kinase domain activation without ligand binding. Mutations concern four exons (9, 11, 13 and 17) but mainly exon 11. We report a new mutation in exon 9, since only AY 502–503 duplication/insertion, FAF 506 insertion and P456S substitution have been previously reported. This mutation consists of a large deletion of 43 nucleotides and an insertion of 25 nucleotides. More surprisingly, the sequence inserted corresponds to the complementary sequence of the wild allele but in the opposite sense. To our knowledge, this mutation has never been previously described. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## Background and objective to analyze the frequency and spectrum of KIT and platelet‐derived growth factor receptor‐alpha (PDGFRA) gene in a large series of study and to explore the clinical implication of mutations in the gastrointestinal stromal tumors (GISTs) in China. ## Method